Tuberculosis treatment by restoring sensitivity to key drugs with Mycobacterial Tolerance Inhibitor
Reference number | |
Coordinator | QURETECH BIO AB - QURETECH BIO AB c/o Akiri AB |
Funding from Vinnova | SEK 4 000 |
Project duration | September 2016 - September 2016 |
Status | Completed |